University of Alabama at Birmingham, Birmingham, Alabama.
University of Texas Health Science Center at Houston, Houston, Texas.
Transfusion. 2020 Mar;60(3):498-506. doi: 10.1111/trf.15675. Epub 2020 Jan 22.
Whole blood trauma resuscitation is conceptually appealing and increasingly used but lacks evidence. A randomized controlled trial is needed but challenging to design. A Bayesian approach might be more efficient and more interpretable than a conventional frequentist design. We report the results on an elicitation meeting to create prior probability distributions to help develop such a trial.
In-person expert elicitation meeting, based on Sheffield Elicitation Framework methodology. We used an interactive graphical tool to elicit the quantities of interest (24-hour mortality and certainty required). Two rounds were conducted, with an intervening discussion of deidentified responses. Individual responses were aggregated into probability distributions.
Fifteen experts participated. The pooled belief was that the median 24-hour mortality of trauma patients with hemorrhagic shock treated with component therapy (the current standard of care) was 19% (95% credible interval [CrI], 6%-45%), and the median 24-hour mortality of those treated with whole blood, 16% (95% CrI, 5%-39%). The pooled prior distribution for the relative risk had a median of 0.84 (95% CrI, 0.26-3.1), indicating that the expert group had a 64% prior belief that whole blood decreases 24-hour mortality compared to component therapy.
Experts had moderately strong beliefs that whole blood reduces the 24-hour mortality of trauma patients with hemorrhagic shock. These data will assist with the design and planning of a Bayesian trial of whole blood resuscitation, which will help to answer a key question in contemporary transfusion practice.
全血创伤复苏在概念上很有吸引力,并且越来越多地被使用,但缺乏证据。需要进行一项随机对照试验,但设计具有挑战性。贝叶斯方法可能比传统的频率派设计更有效和更易于解释。我们报告了一次启发式会议的结果,以创建先验概率分布,以帮助开展此类试验。
基于谢菲尔德启发式框架方法的现场专家启发式会议。我们使用交互式图形工具来引出感兴趣的数量(24 小时死亡率和所需的确定性)。进行了两轮,中间讨论了匿名回复。将个人回复汇总成概率分布。
15 名专家参加了会议。汇总的信念是,接受成分治疗(当前的标准治疗)的失血性休克创伤患者的 24 小时死亡率中位数为 19%(95%可信区间[CrI],6%-45%),而接受全血治疗的患者的 24 小时死亡率中位数为 16%(95%CrI,5%-39%)。相对风险的汇总先验分布中位数为 0.84(95%CrI,0.26-3.1),表明专家组有 64%的先验信念,即全血与成分治疗相比可降低 24 小时死亡率。
专家们强烈认为全血可降低失血性休克创伤患者的 24 小时死亡率。这些数据将有助于全血复苏的贝叶斯试验的设计和规划,这将有助于回答当代输血实践中的一个关键问题。